Title |
A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder
|
---|---|
Published in |
BMC Psychology, October 2014
|
DOI | 10.1186/s40359-014-0041-4 |
Pubmed ID | |
Authors |
Nicholas JK Breitborde, Spencer C Dawson, Cindy Woolverton, David Dawley, Emily K Bell, Kaila Norman, Angelina Polsinelli, Beth Bernstein, Pamela Mirsky, Christine Pletkova, Felix Grucci, Carly Montoya, Bernard Nanadiego, Ehsan Sarabi, Michael DePalma, Francisco Moreno |
Abstract |
Cognitive remediation (CR) has shown significant promise in addressing the cognitive deficits that accompany serious mental illness. However, this intervention does not appear to completely ameliorate the cognitive deficits that accompany these illnesses. D-cycloserine (DCS), an NMDA receptor partial agonist, has been shown to enhance the therapeutic benefits of learning-based psychosocial interventions for psychiatric disorders. Thus, the goal of this study is to examine the utility of combining cognitive remediation and d-cycloserine in the treatment of cognitive deficits among individuals with bipolar disorder. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | 25% |
Canada | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Unknown | 34 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 23% |
Student > Bachelor | 4 | 11% |
Researcher | 3 | 9% |
Student > Doctoral Student | 2 | 6% |
Other | 2 | 6% |
Other | 5 | 14% |
Unknown | 11 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 11 | 31% |
Medicine and Dentistry | 3 | 9% |
Nursing and Health Professions | 2 | 6% |
Biochemistry, Genetics and Molecular Biology | 2 | 6% |
Agricultural and Biological Sciences | 1 | 3% |
Other | 5 | 14% |
Unknown | 11 | 31% |